These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29947550)

  • 1. Blood pressure and heart rate variability are linked with hyperphosphatemia in chronic kidney disease patients.
    Wang Q; Cui Y; Yogendranath P; Wang N
    Chronobiol Int; 2018 Sep; 35(10):1329-1334. PubMed ID: 29947550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of non-dipper circadian rhythm of blood pressure on left ventricular hypertrophy in patients with non-dialysis chronic kidney disease.
    Che X; Mou S; Zhang W; Zhang M; Gu L; Yan Y; Ying H; Hu C; Qian J; Ni Z
    Acta Cardiol; 2017 Apr; 72(2):149-155. PubMed ID: 28597784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circadian heart rate and blood pressure variability considered for research and patient care.
    Singh RB; Cornélissen G; Weydahl A; Schwartzkopff O; Katinas G; Otsuka K; Watanabe Y; Yano S; Mori H; Ichimaru Y; Mitsutake G; Pella D; Fanghong L; Zhao Z; Rao RS; Gvozdjakova A; Halberg F
    Int J Cardiol; 2003 Jan; 87(1):9-28; discussion 29-30. PubMed ID: 12468050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory blood pressure monitoring in the prediction of cardiovascular events and effects of chronotherapy: rationale and design of the MAPEC study.
    Hermida RC
    Chronobiol Int; 2007; 24(4):749-75. PubMed ID: 17701685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riser pattern is a predictor of kidney mortality among patients with chronic kidney disease.
    Nakai K; Fujii H; Watanabe K; Watanabe S; Awata R; Kono K; Yonekura Y; Goto S; Nishi S
    Clin Exp Hypertens; 2016; 38(5):476-81. PubMed ID: 27367452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can nutrition influence circadian rhythm and heart rate variability?
    Singh RB; Weydahl A; Otsuka K; Watanabe Y; Yano S; Mori H; Ichimaru Y; Mitsutake G; Sato Y; Fanghong L; Zhao ZY; Kartik C; Gvozdjakova A
    Biomed Pharmacother; 2001; 55 Suppl 1():115s-124s. PubMed ID: 11774858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
    Hermida RC
    Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart rate and blood pressure variability in children with chronic kidney disease: a report from the CKiD study.
    Barletta GM; Flynn J; Mitsnefes M; Samuels J; Friedman LA; Ng D; Cox C; Poffenbarger T; Warady B; Furth S
    Pediatr Nephrol; 2014 Jun; 29(6):1059-65. PubMed ID: 24488505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian blood pressure classification scheme and the health of patients with chronic kidney disease.
    Agarwal R; Kariyanna SS; Light RP
    Am J Nephrol; 2009; 30(6):536-46. PubMed ID: 19844085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of abnormal diurnal blood pressure variation in healthy late middle-aged and older adults.
    Hamada T; Murata T; Narita K; Takahashi T; Wada Y; Kimura H; Yoshida H
    Blood Press; 2008; 17(3):134-40. PubMed ID: 18608199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
    Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does sympathetic overactivation feature all hypertensives? Differences of sympathovagal balance according to night/day blood pressure ratio in patients with essential hypertension.
    Di Raimondo D; Miceli G; Casuccio A; Tuttolomondo A; Buttà C; Zappulla V; Schimmenti C; Musiari G; Pinto A
    Hypertens Res; 2016 Jun; 39(6):440-8. PubMed ID: 26865002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peculiarities of regulatory mechanisms of autonomic nervous system in patients with arterial hypertension and disturbed 24-hour blood pressure profile].
    Tikhonov PP; Sokolova LA
    Kardiologiia; 2007; 47(1):16-21. PubMed ID: 17426676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Reverse Dipper Blood Pressure Pattern in Chronic Kidney Disease Patients not Undergoing Dialysis: Prospective Cohort Study.
    Wang C; Ye Z; Li Y; Zhang J; Zhang Q; Ma X; Peng H; Lou T
    Sci Rep; 2016 Oct; 6():34932. PubMed ID: 27713498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The autonomic nervous activity of hypertension].
    Ohisa N; Imai Y; Hashimoto J; Yoshida K; Kaku M
    Rinsho Byori; 2002 Sep; 50(9):899-905. PubMed ID: 12386969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular and cerebrovascular disease].
    Kanda T; Takeda A; Kawabe H
    Nihon Rinsho; 2014 Aug; 72(8):1435-9. PubMed ID: 25167749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
    ; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
    Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Niacin and Chronic Kidney Disease.
    Taketani Y; Masuda M; Yamanaka-Okumura H; Tatsumi S; Segawa H; Miyamoto K; Takeda E; Yamamoto H
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S173-5. PubMed ID: 26598845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.